Twitter Beğeni Hilesi

woMMan of #Myeloma Nina Shah Irene Ghobrial marivi mateos Gurbakhash Kaur Surbhi Sidana, MD Noopur Raje Krina Patel Yi Lin Paula Rodriguez-Otero Eloisa Cartaxo VaniaHungria Ayk and many more. #mmsm #IMFIMWG #IMWG2024 #woMMan

Carrington is the GOAT!!! Unreal 8th Gold Medal 🥇 🔥 Put her up there with the greats #Olympic2024 #NewZealand

Dr Raygun has achieved a feat absolutely unheard of in academia - people are reading her thesis

Impt visit to ⁦Australian Government⁩ with ⁦Leukaemia Foundation⁩ ⁦⁦patients⁩ advocating for better blood cancer patient support (looking at you Dept of Social Services) & research funding: followed by a lighthearted #break on the way out. Ready for the transplant games. #raygun

💃 Keep an eye out for our volunteers in red this Sunday at the City of Canada Bay Ferragosto. We'll be selling our raffle tickets, with more than $10,000 worth of prizes to be won! 👋 Grab your coffee, cannoli and buy your winning ticket from one of our Bloody Great Volunteers!

The fortress! What an emphatic reply at what must be the toughest ground in world rugby. @allblacks 50 games without defeat Eden Park, Auckland #NZL 42 #ARG 10.

Thank-you Chris for your engagement with our consumer representative panel, articulating & amplifying the patient voice. “No research about me without me”.

Today is World CLL Day. ALLG’s CLL Leaders are working with our dedicated members to develop new trials to improve treatments, outcomes and quality of life for CLL patients. Find out more: allg.org.au.

ALLG’s Myeloma leaders recently attend the @MyelomaAus National Workshop in Melbourne, where Dr Georgia McCaughan presented an informative update on ALLG’s myeloma clinical trials. Read more about our Myeloma trials in our Research Report: tinyurl.com/ycxzznah.

Today is World Leukaemia Day. 1/3 of ALLG trials are in leukaemia. In AML, the AMLM26 INTERCEPT trial has been approved to open at MD Anderson Cancer Center, providing world-first molecularly targeted therapies to prolong remission & survival. For more: allg.org.au.

Three patients of mine treated with Mosun at 1.6mg q3weeks back in 2016, have remained in remission. Mosun was approved in 12.2022. The GO29781 clinical trial gave them access to “tomorrow’s medicine” 6 years earlier.

Dr Tara Graff highlighting key elements to bring bispecific therapy into the community 👊 🌟 communication is 👸 queen 🌟 Society of Hematologic Oncology (SOHO) Women In Lymphoma - [email protected] Mission Cancer + Blood

Sobering summary of global inequity of access & outcome in CAR-T Society of Hematologic Oncology (SOHO) by Astrid Pavlovsky #SOHO24

Congratulations Society of Hematologic Oncology (SOHO) on such diversity in gender and geographic presentations at an excellent educational meeting #SOHO2024

ALLG’s team met with Dr Othman Al-Sawaf from the German CLL study group (GCLLSG) to discuss upcoming trial collaborations, new CLL concepts & ALLG’s teletrial model. International collaborations are key to driving impact for blood cancer patients, visit allg.org.au.

Last year we had Barbenheimer, now this year, just a week apart, comes… GLADDINGTON 🐻⚔️

We’re ready to party: with Our Patients, Our Partners in Research. Robin Gasiorowski Janlyn Falconer Nicole Wong Doo

Air New Zealand pilot of Indian descent fluent in te reo Māori a lesson that when te Tiriti, te reo and diversity come together we are an awesome Aotearoa.

Today is World Lymphoma Awareness Day. Over 1/3 of ALLG trials are in lymphoma, with a priority to ensure equitable access to patients across Australia & NZ. Thanks to the ALLG NHL35 PACIFIC trial, Lauren is in remission from her lymphoma. Read more, allg.org.au.

Lymphoma is the fifth most common cancer. Do you know the symptoms? Share to spread the word this #WorldLymphomaAwarenessDay. Find out more about lymphoma from LymphomaAction: lymphoma-action.org.uk/about-lymphoma